PHOTOPHERESIS IN THE COMPREHENSIVE TREATMENT OF UROGENITAL REACTIVE ARTHRITIS (REITER’S DISEASE)

Cover Page


Cite item

Full Text

Abstract

The article reports successful use of extracorporeal photochemotherapy (photopheresis) in the comprehensive treatment of 9 patients with urogenital reactive arthritis (Reiter’s disease).

About the authors

M. S. Petrova

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Author for correspondence.
Email: marina.s.petrova@gmail.com
Research Associate, Dermatovenereology and Dermato-Oncology Department Russian Federation

A. V. Kil’dyushevskiy

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Email: fake@neicon.ru
MD, PhD, Professor, Leading Research Associate, Surgical Hemocorrection and Detoxication Department Russian Federation

Yu. V. Molochkova

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Email: fake@neicon.ru
Research Associate, Dermatovenereology and Dermato-Oncology Department Russian Federation

References

  1. Ковалев ЮН, Ильин ИИ. Болезнь Рейтера. Челябинск: Вариант-книга; 1993. 224 c. (Kovalev YuN, Il’in II. Reiter’s disease. Chelyabinsk: Variant-kniga; 1993. 224 p. Russian).
  2. Carter JD, Gérard HC, Espinoza LR, Ricca LR, Valeriano J, Snelgrove J, Oszust C, Vasey FB, Hudson AP. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum. 2009;60(5):1311–6.
  3. Хансфилд Х. Заболевания, передающиеся половым путем. Цветной атлас-справочник. [Пер. с англ.]. М.: БИНОМ; 2004. 296 c. (Handsfield H. Sexually transmitted diseases. Color reference atlas. Moscow: BINOM; 2004. 296 p. Russian).
  4. Arora S, Arora G. Reiter’s disease in a six-year-old girl. Indian J Dermatol Venereol Leprol. 2005;71(4):285–6.
  5. Laasila K, Laasonen L, Leirisalo-Repo M. Antibiotic treatment and long term prognosis of reactive arthritis. Ann Rheum Dis. 2003;62(7):655–8.
  6. Magro СM, Crowson AN, Peeling R. Vasculitis as the basis of cutaneous lesions in Reiter’s disease. Hum Pathol. 1995;26(6):633–8.
  7. Mazzoli S, Meacci F, Cosco E, Poggiali C. Clinical consequences of immune responses to Chlamydia in men. Infect Dis Obstet Gynecol. 1996;4(3):136–42.
  8. Молочков ВА, Альбанова ВИ, Петрова МС, Белецкая ЛВ. Результаты сравнительных гистологических и иммуноморфологических изменений кожи при болезни Рейтера и псориазе. Российский журнал кожных и венерических болезней. 2001;(3):13–7. (Molochkov VA, Al’banova VI, Petrova MS, Beletskaya LV. [Comparison of histological and immunomorphological skin changes in Reiter’s disease and psoriasis]. Rossiyskiy zhurnal kozhnykh i venericheskikh bolezney. 2001;(3):13–7. Russian).
  9. Clegg DO, Reda DJ, Weisman MH, Cush JJ, Vasey FB, Schumacher HR Jr, Budiman-Mak E, Balestra DJ, Blackburn WD, Cannon GW, Inman RD, Alepa FP, Mejias E, Cohen MR, Makkena R, Mahowald ML, Higashida J, Silverman SL, Par-hami N, Buxbaum J, Haakenson CM, Ward RH, Manaster BJ, Anderson RJ, Ward JR, Hender-son WG. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter’s syndrome). A department of veterans affairs cooperative study. Arthritis Rheum. 1996;39(12):2021–7.
  10. Louthrenoo W. Successful treatment of severe Reiter’s syndrome associated with human immunodeficiency virus infection with etretinate. Report of 2 cases. J Rheumatol. 1993;20(7):1243–6.
  11. Williams HC, Du Vivier AW. Etretinate and AIDS-related Reiter’s disease. Br J Dermatol. 1991;124(4):389–92.
  12. Yli-Kerttula T, Möttönen T, Toivanen A. Different course of reactive arthritis in two HLA-B27 positive brothers with fatal outcome in one. J Rheumatol. 1997;24(10):2047–50.
  13. Meador R, Hsia E, Kitumnuaypong T, Schumacher HR. TNF involvement and anti-TNF therapy of reactive and unclassified arthritis. Clin Exp Rheumatol. 2002;20(6 Suppl 28):S130–4.
  14. Kaipiainen-Seppänen O, Niinisalo H, Korpilähde T, Virolainen J. Treatment of reactive arthritis with infliximab. Scand J Rheumatol. 2003;32(2):122–4.
  15. Felipe OJ, Beltrán A, Romero MC, Valle RR. Сlinical response to infliximad in a patient diagnosed with reactive arthritis at the hospital militar central in Bogota. J Clin Rheumatol. 2006;12 Suppl 4:S68.
  16. Rihl M, Klos A, Köhler L, Kuipers JG. Infection and musculoskeletal conditions: Reactive arthritis. Best Pract Res Clin Rheumatol. 2006;20(6): 1119–37.
  17. Flores D, Marquez J, Garza M, Espinoza LR. Reactive arthritis: newer developments. Rheum Dis Clin North Am. 2003;29(1):37–59.
  18. Молочков ВА, Ильин ИИ. Хронический уретрогенный простатит. М.: Медицина; 2004. 288 c. (Molochkov VA, Il’in II. Chronic urethrogenic prostatitis. Moscow: Meditsina; 2004. 288 p. Russian).

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Petrova M.S., Kil’dyushevskiy A.V., Molochkova Y.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies